<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>TETRAVISC - tetracaine hydrochloride liquid </strong><br>OCuSOFT, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>TetraVisc Hydrochloride Ophthalmic
Solution, USP 0.5% Viscous Sterile
              Rx Only</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTON:</h1>
<br>Tetracaine Hydrochloride 0.5% is a sterile topical ophthalmic solution useful in producing surface anesthesia of the eye. The<br>active ingredient is represented by the structural formula:<br><br><br>CH<span class="Sub">3(</span>CH<span class="Sub">2)3</span>NH <span class="Emphasis">     COOCH2CH2N(CH3)2<span class="Sup">.</span>HCI<span class="Emphasis"><br><br></span><br></span>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>
<p class="First">Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% acts by decreasing the permeability of the neuronal membrane,<br>thereby decreasing the flux of sodium, potassium and other ions associated with propagation of the nerve impulse. The onset<br>of anesthesia usually begins within 30 seconds and lasts a relatively short period of time.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">For procedures in which a rapid and short acting topical ophthalmic anesthetic is indicated such as in tonometry, gonioscopy,<br>removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, suture removal from the cornea or conjunctiva,<br>other short corneal and conjunctival procedures.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<p class="First">Should not be used by the patient without physician supervision, or in those persons showing <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any component<br>of this preparation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<p class="First">For topical ophthalmic use only. Not for parenteral use. Not for injection. Do not use solution if it contains crystals or if it is cloudy<br>or discolored. Prolonged use results in diminished duration of anesthesia and retarded healing. This may cause the drug to be<br>used more frequently, creating a "vicious circle". Subsequent <span class="product-label-link" type="condition" conceptid="4208814" conceptname="Corneal infection">corneal infection</span> and/or corneal opacification with accompanying<br>permanent visual loss or <span class="product-label-link" type="condition" conceptid="4326414" conceptname="Perforation of cornea">corneal perforation</span> may occur. Prolonged use may also produce severe <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>General:</h1>
<p class="First">Do not touch dropper tip to any surface as this may contaminate the solution. As with all anesthetics, continuous and prolonged<br>use should be avoided. Protection of the eye from irritating chemicals, foreign bodies and rubbing during the period of<br>anesthesia is very important. Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% should be used cautiously in patients<br>with known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> or cardiac disease. If signs of sensitivity develop during the treatment or irritation persists or increases,<br>patients should be advised to discontinue use and consult prescribing physician.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7"></a><p></p>
<p class="First">Keep this and all drugs out of the reach of children . In case of accidental ingestion, seek professional assistance or contact a<br>Poison Control Center immediately.<br>After instillation of this product, the surface of the eye is insensitive and can be scratched without your feeling it. Do not rub<br>eye. Do not instill this product repeatedly because severe eye damage may occur.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-8"></a><p></p>
<p class="First">No studies have been conducted in animals or in humans to evaluate the potential of these effects.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-9"></a><p></p>
<h1>Pregnancy Category C:</h1>
<p class="First">Animal reproduction studies have not been performed with Tetracaine Hydrochloride. It is also not known whether Tetracaine<br>Hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction. Tetracaine<br>Hydrochloride Ophthalmic Solution, USP 0.5% should be given to pregnant women only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-10"></a><p></p>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should<br>be excercised when Tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-11"></a><p></p>
<h1>Pediatric Use:</h1>
<p class="First">Safety and effectiveness in children have not been established.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-12"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First">Transient symptoms (signs) such as <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, burning, and <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival redness</span> may occur. A rare, severe, immediate type<br>allergic corneal reaction has been reported characterized by acute diffuse epithelial <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span> with filament formation and/or<br><span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">sloughing</span> of large areas of necrotic epithelium, diffuse stromal <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">descemetitis</span> and <span class="product-label-link" type="condition" conceptid="4274964" conceptname="Iritis">iritis</span>.</p>
<p>To report SUSPECTED ADVERSE REACTIONS, contact OCuSOFT, Inc. at (800) 233-5469 www.ocusoft.com.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-13"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:
Dosage:</h1>
<p class="First">One to two drops per eye.<br>For Tonometry And Other Procedures Of Short Duration:<br>Instill one or two drops just prior to evaluation.<br>For Minor Surgical Procedures Such As Foreign Body Or Suture Removal:<br>Instill one or two drops in the eye(s) every five to ten minutes maximum three doses.<br>For Prolonged Anesthesia As In <span class="product-label-link" type="condition" conceptid="375545" conceptname="Cataract">Cataract</span> Extraction:<br>Instill one or two drops in the eye(s) every five to ten minutes maximum five doses.<br></p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-14"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">Tetracaine Hydrochloride Ophthalmic Solution , USP 0.5% is supplied in:<br>5 mL multi-drop plastic container NDC 54799-505-05<br>0.6 mL single unit dose plastic container NDC 54799-505-01</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-15"></a><p></p>
<h1>Storage:</h1>
<p class="First">Store at a room temperature, 15°-30°C (59°-86°F).<br>Keep container tightly closed.</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-16"></a><p></p>
<p class="First"><img alt="tetravisc bottle label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8534f262-6755-4a3c-980b-c25a6c9110e4&amp;name=tetravisc1.jpg"><br></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-17"></a><p></p>
<p class="First"><img alt="tetravisc bottle label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8534f262-6755-4a3c-980b-c25a6c9110e4&amp;name=tetravisc2.jpg"></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-18"></a><p></p>
<p class="First"><img alt="structural formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=8534f262-6755-4a3c-980b-c25a6c9110e4&amp;name=tetravisc3.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TETRAVISC 		
					</strong><br><span class="contentTableReg">tetracaine hydrochloride liquid</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54799-505</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Tetracaine Hydrochloride</strong> (Tetracaine) </td>
<td class="formItem">Tetracaine Hydrochloride</td>
<td class="formItem">25 mg  in 5 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Boric Acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Edetate Disodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Hypromelloses</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Potassium Chloride</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sodium Borate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Sodium Chloride</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Hydrochloric Acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Sodium Hydroxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BENZALKONIUM CHLORIDE    </strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54799-505-05</td>
<td class="formItem">5 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:54799-505-01</td>
<td class="formItem">0.6 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">08/02/2005</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>OCuSOFT, Inc.
							(174939207)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>OCuSOFT, Inc. (174939207)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Altaire Pharmaceuticals, Inc.</td>
<td class="formItem"></td>
<td class="formItem">786790378</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 5/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>12cb00e5-6494-4bfe-afa3-9cf5cf6c2211</div>
<div>Set id: 8534f262-6755-4a3c-980b-c25a6c9110e4</div>
<div>Version: 3</div>
<div>Effective Time: 20110519</div>
</div>
</div> <div class="DistributorName">OCuSOFT, Inc.</div></p>
</body></html>
